Thorens G
Division of Addictology, Department of Psychiatry, Geneva University Hospitals, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
ArticlePsilocybin
Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.
PreprintPsilocybin
Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland
PreprintPsilocybin
Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement
ArticlePsilocybin
[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]
ArticlePsychedelics
Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy
ArticlePsychedelics
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.
ArticlePsilocybin
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.
ArticlePsilocybin
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.
ArticleKetamine
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs.
ArticleLSD